Systematic uncovering of multiple pathways underlying the pathology of Huntington disease by an acid-cleavable isotope-coded affinity tag approach.
Huntington disease (HD) is an autosomal dominant neurodegenerative disease that results from a CAG (glutamine) trinucleotide expansion in exon 1 of huntingtin (Htt). The aggregation of mutant Htt has been implicated in the progression of HD. The earliest degeneration occurs in the striatum. To identify proteins critical for the progression of HD, we applied acid-cleavable ICAT technology to quantitatively determine changes in protein expressions in the striatum of a transgenic HD mouse model (R6/2). The cysteine residues of striatal proteins from HD and wild-type mice were labeled, respectively, with the heavy and light forms of the ICAT reagents. Samples were trypsinized, uncovered by avidin affinity chromatography, and analyzed by nano-LC-MS/MS. Western blot analyses were used to confirm and to calibrate the ICAT ratios. Linear regression was used to uncover a group of proteins that exhibited consistent changes. In two independent ICAT experiments, we identified 427 cysteine-containing striatal proteins among which approximately 66% (203 proteins) were detected in both ICAT experiments. Approximately two-thirds of proteins identified in each ICAT experiment were detected in both ICAT experiments. In total, 68 proteins with altered expressions in HD mice were identified. Elevated expressions of two down-regulated proteins (14-3-3sigma and FKBP12) effectively reduced Htt aggregates in a striatal cell line, supporting the functional relevance of the above findings. Collectively by using a well defined protocol for data analysis, large scale comparisons of protein expressions by ICAT can be reliable and can provide valuable clues for identifying proteins critical for pathophysiological functions.
Chiang
Ming-Chang
MC
Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan.
Juo
Chiun-Gung
CG
Chang
Hao-Hung
HH
Chen
Hui-Mei
HM
Yi
Eugene C
EC
Chern
Yijuang
Y
D048948:14-3-3 Proteins / Q000235:genetics; D000818:Animals; D015153:Blotting, Western; D001923:Brain Chemistry; D002853:Chromatography, Liquid; D015536:Down-Regulation; D005260:Female; D006816:Huntington Disease / Q000378:metabolism*; D007553:Isotope Labeling / Q000379:methods*; D016014:Linear Models; D008297:Male; D053858:Metabolic Networks and Pathways; D051379:Mice; D008815:Mice, Inbred Strains; D008822:Mice, Transgenic; D011506:Proteins / Q000737:chemistry*; D040901:Proteomics; D022061:Tacrolimus Binding Protein 1A / Q000235:genetics; D053719:Tandem Mass Spectrometry; D015854:Up-Regulation
D048948:14-3-3 Proteins; D011506:Proteins; D022061:Tacrolimus Binding Protein 1A